Our Optotracers: EbbaBiolight, Carbotrace and Amytracker

Optotracing is an innovative visualization method developed by scientists for scientists ideal to use in fluorescence microscopy. With optotracing – using fluorescent tracer molecules – Ebba Biotech provides an innovative method for several expanding areas of research. The optotracing technology has been developed by a scientific expert team of researchers at Karolinska Institutet, Linköping University and the Royal Institute of Technology (KTH) in Sweden and is a result of many years of cutting-edge nanoscience and organic chemistry research.

Ebba Biotech has commercialized distribution and sales of fluorescent tracer molecules and today supply these in three different series:

Optotracers for labeling amyloids and other protein aggregates

Optotracers for carbohydrate analysis and anatomical mapping

Optotracers for detection of bacteria and bacterial biofilm

Video clips about Optotracing

On the first of June 2021, Ferdinand Choong, Ebba Biotech's co-founder, and Assistant Professor at Karolinska Institutet and AIMES (Center for the Advancement of Integrated Medical and Engineering), presented his research using Ebba Biotech's optotracers at the digital event Lab & Diagnostics of the Future 2021, held by Life Science Sweden. At this event, Ferdinand spoke about Ebba Biotech's optotracers multifunctional tracer for disease research and diagnostics. He explains the technical concept in large and Ebba Biotech's three product series.

The video clip about optotracing illustrates why our current model of Take, Make, Dispose is draining our planet of natural resources and why circular economy and renewable resources are the answer. Learn how Optotracers can be used to identify renewable resources in plant biomass and support circular economy in the food & beverage, pharmaceutical and chemical industry.

In the first episode of our webinar series about EbbaBiolight, Dr. Karen Butina present her research findings using optotracers for detection and quantification of Staphylococci. You can read more about Dr. Butina's work here. DISCLAIMER: Dr. Butina describes her work using HS-167 molecules. These are predecessor molecules to what is now commercialised under the product family name EbbaBiolight, which are marketed and sold by Ebba Biotech.